PR Newswire: Agnitio today announced that Ascensia Diabetes Care has selected its Rainmaker multichannel communication solution for use worldwide.
Rainmaker is an advanced communication solution that enables life science companies to deliver high-value communications to healthcare professionals in multiple channels — including e-detailing, remote engagement, microsites and email communication.
The agreement covers 28 countries and will add a further 700 users to the Rainmaker platform, with the potential to grow in the future. In addition to the solution itself, Ascensia will also be working with Agnitio Services, for complete support on implementation, training, analytics and project management. Ascensia will integrate Rainmaker with their CRM system and deploy content to both iOS and Windows tablets.
Elaine Pearton, Global Digital Marketing Manager at Ascensia Diabetes Care said: “Rainmaker enables us to provide a quality multichannel experience to healthcare professionals while being easy to work with. In particular, we were attracted to Rainmaker’s ability to re-use content across channels. This, combined with the ease of adapting materials, enables Ascensia to respond even faster to the needs of healthcare professionals.”
Lars Diemer, Agnitio CEO, said: “This is an important agreement for Agnitio and a recognition of the value that our investment in Rainmaker brings life science companies. We look forward to developing our partnership with Ascensia and ensure they achieve their communication objectives within diabetes care.”
Agnitio creates digital communication solutions for the life sciences. The company’s work is anchored in the belief that technology can make communication more relevant for healthcare professionals and patients. By providing systems that impact at an individual level – and solve people’s real problems – Agnitio’s solutions enable life science companies to deliver high value to physicians and their patients to improve treatment outcomes.
About Ascensia Diabetes Care
Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes. The company’s mission is to empower people living with diabetes through innovative solutions that simplify and improve their lives. Ascensia Diabetes Care uses their innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a positive, daily difference for people with diabetes.
Home to the world renowned CONTOURTM portfolio of blood glucose monitoring systems, Ascensia Diabetes Care’s products combine advanced technology with user-friendly functionality that help people with diabetes to manage their condition. Ascensia Diabetes Care is committed to continued research, innovation and development of new products and solutions. As a trusted partner in the diabetes community, they collaborate closely with healthcare professionals and other partners to ensure their products meet the highest standards of accuracy, precision and reliability, and that they conduct their business compliantly and with integrity.
Ascensia Diabetes Care was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd. Ascensia Diabetes Care products are sold in more than 125 countries. Following the close of the transaction in all countries, Ascensia Diabetes Care will have around 1,700 employees and operations in 38 countries.
For further information please visit the Ascensia Diabetes Care website at: http://www.ascensia.com.
CONTOUR™ is a registered trademark of Ascensia Diabetes Care Holdings AG
Read press release on PR Newswire
Suggested further reading